Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
Knowledge of 18-19 Years Old About Papillomavirus and HPV Vaccination
Today, cancers associated with papillomavirus infection affect 6,300 new people each year in France, men and women combined. The papillomavirus vaccine is currently the only vaccine that protects against HPV-associated cancers. However, in its report on vaccination coverage for 2024, Santé Publique France reveals that 41.5% and 37.4% of the 18- and 19-year-old French population respectively have a complete vaccination schedule.
Information, education and communication about HPV are essential to enable the entire population to make informed and responsible decisions about HPV.
Increasing information and immunization coverage for papillomavirus is part of the government's ambitious health plans with the national sexual health strategy and college vaccination campaign.
The main objective is to describe knowledge of girls and boys aged 18-19 about papillomavirus and HPV vaccination
Inclusion Criteria:
Boys and girls 18 to 19 years of age Vaccinated or not against HPV Sexually active or not Agreeing to take part in the study
Exclusion Criteria:
Minors Age 20 and over Protected by law (guardianship, curatorship, safeguard of justice) Not wishing to answer the questionnaire